-+ 0.00%
-+ 0.00%
-+ 0.00%

Cellectar Biosciences Announces 1-For-30 Reverse Stock Split, Effective June 24, 2025

Benzinga·06/18/2025 20:32:25
Listen to the news

Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced a one-for-thirty reverse stock split (the "Reverse Stock Split") of the company's common stock, par value $0.00001, which will become effective at 12:01 a.m. Eastern Time on Tuesday, June 24, 2025. The company's common stock will continue to trade under its current trading symbol, CLRB, on the Nasdaq Global Select Market ("Nasdaq") on a split-adjusted basis when the market opens on Tuesday, June 24, 2025, with the new CUSIP number 15117F880.